摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(5-Bromo-2-phenylmethoxyphenyl)-2-methyl-1,3-dioxolane | 894099-87-7

中文名称
——
中文别名
——
英文名称
2-(5-Bromo-2-phenylmethoxyphenyl)-2-methyl-1,3-dioxolane
英文别名
——
2-(5-Bromo-2-phenylmethoxyphenyl)-2-methyl-1,3-dioxolane化学式
CAS
894099-87-7
化学式
C17H17BrO3
mdl
——
分子量
349.224
InChiKey
JGPKFOCPOKPIJX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    27.7
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(5-Bromo-2-phenylmethoxyphenyl)-2-methyl-1,3-dioxolane三乙基硅烷正丁基锂三氟化硼乙醚 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 3.5h, 生成 1-(2-(benzyloxy)-5-(α-D-fucofuranosyl))phenyl ethanone
    参考文献:
    名称:
    Stereoselective C-glycosidation of d-fucose derivatives directed by the protective groups
    摘要:
    Stereoselectivity in the C-glycosidation of lactones derived from D-fucose by following Kishi's method, which involves the addition of a nucleophile onto a carbohydrate-derived lactone and subsequent reduction of the lactol, was found to be reliant on the nature of the C2 and C3 protective groups. Lactones bearing TBDMS protecting groups selectively afford 1,3-trans products (alpha anomer), in which the stereoselective outcome is in apparent concordance with Woerpel's model. On the other hand, their benzylated congeners produce the 1,3-cis products (beta anomer) as the major diastereoisomers. The latter results suggest an abnormal behavior during the stereoselective nucleophilic substitution at the anomeric position of the benzylated lactones. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.carres.2014.04.005
  • 作为产物:
    参考文献:
    名称:
    Stereoselective C-glycosidation of d-fucose derivatives directed by the protective groups
    摘要:
    Stereoselectivity in the C-glycosidation of lactones derived from D-fucose by following Kishi's method, which involves the addition of a nucleophile onto a carbohydrate-derived lactone and subsequent reduction of the lactol, was found to be reliant on the nature of the C2 and C3 protective groups. Lactones bearing TBDMS protecting groups selectively afford 1,3-trans products (alpha anomer), in which the stereoselective outcome is in apparent concordance with Woerpel's model. On the other hand, their benzylated congeners produce the 1,3-cis products (beta anomer) as the major diastereoisomers. The latter results suggest an abnormal behavior during the stereoselective nucleophilic substitution at the anomeric position of the benzylated lactones. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.carres.2014.04.005
点击查看最新优质反应信息

文献信息

  • [EN] NOVEL 3-(2-AMINO-6-PYRIDINYL)-4-HYDROXYPHENYL AMINE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS DE 3-(2-AMINO-6-PYRIDINYL)-4-HYDROXYPHÉNYLAMINE
    申请人:LG LIFE SCIENCES LTD
    公开号:WO2006068410A1
    公开(公告)日:2006-06-29
    [EN] The present invention relates to novel compounds having 3-(2-amino-6-pyrimidinyl)-4-hydroxyphenyl amine structure, as being illustrated in Formula 1, and preparations for preparation of them, and the use of them, and pharmaceutical compositions containing them at a therapeutically effective amount. The compounds according to the present invention are useful for the treatment and prevention of diseases resulting from the undesired KDR activity, for example, angiogenesis-related diseases such as cancers, psoriasis, rheumatoid arthritis, diabetic retinopathy, etc.
    [FR] La présente invention concerne de nouveaux composés de structure 3-(2-amino-6-pyrimidinyl)-4-hydroxyphénylamine, tels qu'illustrés par la Formule 1, ainsi que leurs méthodes de synthèse, leurs applications, et des préparations pharmaceutiques contenant lesdits composés à des teneurs thérapeutiques. Les composés selon la présente invention peuvent être employés dans le traitement prophylactique et thérapeutique de maladies dues à une activité anormale de KDR, par exemple des maladies de type angiogenèse telles que les cancers, le psoriasis, la polyarthrite rhumatoïde, la rétinopathie diabétique, etc.
  • Stereoselective C-glycosidation of d-fucose derivatives directed by the protective groups
    作者:Omar Cortezano-Arellano、Camilo A. Meléndez-Becerra、Fernando Cortés、Fernando Sartillo-Piscil、Alejandro Cordero-Vargas
    DOI:10.1016/j.carres.2014.04.005
    日期:2014.7
    Stereoselectivity in the C-glycosidation of lactones derived from D-fucose by following Kishi's method, which involves the addition of a nucleophile onto a carbohydrate-derived lactone and subsequent reduction of the lactol, was found to be reliant on the nature of the C2 and C3 protective groups. Lactones bearing TBDMS protecting groups selectively afford 1,3-trans products (alpha anomer), in which the stereoselective outcome is in apparent concordance with Woerpel's model. On the other hand, their benzylated congeners produce the 1,3-cis products (beta anomer) as the major diastereoisomers. The latter results suggest an abnormal behavior during the stereoselective nucleophilic substitution at the anomeric position of the benzylated lactones. (C) 2014 Elsevier Ltd. All rights reserved.
查看更多